These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22075229)

  • 1. [Acinetobacter baumannii. An opportunistic pathogen offside?].
    Gobernado Serrano M
    Med Clin (Barc); 2012 Mar; 138(5):204-6. PubMed ID: 22075229
    [No Abstract]   [Full Text] [Related]  

  • 2. Acinetobacter baumannii: an emerging opportunistic pathogen.
    Howard A; O'Donoghue M; Feeney A; Sleator RD
    Virulence; 2012 May; 3(3):243-50. PubMed ID: 22546906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are we closing in on an "elusive enemy"? The current status of our battle with Acinetobacter baumannii.
    Perez F; Ponce-Terashima R; Adams MD; Bonomo RA
    Virulence; 2011; 2(2):86-90. PubMed ID: 21499025
    [No Abstract]   [Full Text] [Related]  

  • 4. Back to basics--optimizing the use of available resources during an outbreak of multi-drug resistant Acinetobacter spp.
    De Jong G; Duse A; Richards G; Marais E
    J Hosp Infect; 2004 Jun; 57(2):186-7. PubMed ID: 15183255
    [No Abstract]   [Full Text] [Related]  

  • 5. Acinetobacter baumannii resistant to everything: what should we do?
    Vila J; Pachón J
    Clin Microbiol Infect; 2011 Jul; 17(7):955-6. PubMed ID: 21722248
    [No Abstract]   [Full Text] [Related]  

  • 6. Acinetobacter baumannii: an emerging multidrug-resistant threat.
    Gootz TD; Marra A
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outbreak of NDM-1-producing Acinetobacter baumannii in France, January to May 2013.
    Decousser JW; Jansen C; Nordmann P; Emirian A; Bonnin RA; Anais L; Merle JC; Poirel L
    Euro Surveill; 2013 Aug; 18(31):. PubMed ID: 23929226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the way of dealing with antibiotic exposure in studies assessing risk factors for drug-resistant pathogens.
    Prates CG; Zavascki AP
    Diagn Microbiol Infect Dis; 2009 May; 64(1):102; author reply 103. PubMed ID: 19232855
    [No Abstract]   [Full Text] [Related]  

  • 9. Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital.
    Alp E; Esel D; Yildiz O; Voss A; Melchers W; Doganay M
    Scand J Infect Dis; 2006; 38(5):335-40. PubMed ID: 16709534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic characterization of Acinetobacter baumannii isolates from intensive care units at a tertiary-care hospital in Egypt.
    Nageeb W; Kamel M; Zakaria S; Metwally L
    East Mediterr Health J; 2014 Apr; 20(3):203-11. PubMed ID: 24950079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.
    Durante-Mangoni E; Zarrilli R
    Future Microbiol; 2011 Apr; 6(4):407-22. PubMed ID: 21526942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confronting multidrug-resistant Acinetobacter baumannii: a review.
    Neonakis IK; Spandidos DA; Petinaki E
    Int J Antimicrob Agents; 2011 Feb; 37(2):102-9. PubMed ID: 21130607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of an outbreak of multidrug-resistant Acinetobacter baumannii in trauma intensive care unit.
    El Shafie SS; Alishaq M; Leni Garcia M
    J Hosp Infect; 2004 Feb; 56(2):101-5. PubMed ID: 15019220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of an Acinetobacter baumannii multidrug resistance endemic in the ICU. Recalling the obvious.
    Escudero D; Cofiño L; Forcelledo L; Quindós B; Calleja C; Martín L
    Med Intensiva; 2017 Nov; 41(8):497-499. PubMed ID: 28081920
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of antimicrobial-resistant Acinetobacter in hospitals.
    Pitt T
    Nurs Stand; 2007 May 9-15; 21(35):51-6. PubMed ID: 17515153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acinetobacter baumannii: a nosocomial pathogen difficult to control].
    Cisneros JM; Pachón J
    Enferm Infecc Microbiol Clin; 2003 May; 21(5):221-3. PubMed ID: 12732110
    [No Abstract]   [Full Text] [Related]  

  • 17. Endemic carbapenem-resistant Acinetobacter baumannii in a Brazilian intensive care unit.
    dos Santos Saalfeld SM; Fukita Viana G; Dias Siqueira VL; Cardoso CL; Botelho Garcia L; Bronharo Tognim MC
    J Hosp Infect; 2009 Aug; 72(4):365-8. PubMed ID: 19541388
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An outbreak of Acinetobacter baumannii in an intensive care unit: epidemiological and molecular findings.
    Longo B; Pantosti A; Luzzi I; Placanica P; Gallo S; Tarasi A; Di Sora F; Monaco M; Dionisi AM; Volpe I; Montella F; Cassone A; Rezza G
    J Hosp Infect; 2006 Nov; 64(3):303-5. PubMed ID: 16978736
    [No Abstract]   [Full Text] [Related]  

  • 20. Management and control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Alfandari S; Gois J; Delannoy PY; Georges H; Boussekey N; Chiche A; Meybeck A; Patoz P; Blondiaux N; Senneville E; Melliez H; Leroy O
    Med Mal Infect; 2014 May; 44(5):229-31. PubMed ID: 24840286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.